Stock QPT QUEST PHARMATECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Quest PharmaTech Inc.

Equities

QPT

CA74836M1068

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 09:49:37 2024-04-25 am EDT 		5-day change 1st Jan Change
0.02 CAD -42.86% Intraday chart for Quest PharmaTech Inc. -42.86% -63.64%
Jan. 30 Quest PharmaTech Brief: Says Quest has a 42.5% ownership interest in OncoQuest; Adds dividend income will be used by Quest for general corporate purposes MT
Jan. 30 Quest PharmaTech Brief: Received a cash dividend payment from OncoQuest Inc. of approximately C$685,000 MT

Business Summary

Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.

Managers

Managers TitleAgeSince
Ragupathy Madiyalakan CEO
 Chief Executive Officer - 04-06-16
Pierre Vermette DFI
 Director of Finance/CFO - 04-12-31
Eliel Bayever CTO
 Chief Tech/Sci/R&D Officer - -

Members of the board

Members of the board TitleAgeSince
Ragupathy Madiyalakan CEO
 Chief Executive Officer - 04-06-16
J. Lievonen CHM
 Chairman - 21-07-04
Jeffrey Shon BRD
 Director/Board Member - 21-07-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 169,129,247 140,179,247 ( 82.88 %) 0 82.88 %

Shareholders

NameEquities%Valuation
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
14.78 %
25,000,000 14.78 % 525 000 $
Ragupathy Madiyalakan
1.892 %
3,200,000 1.892 % 67 200 $
Pierre Vermette
1.042 %
1,761,518 1.042 % 36 992 $
Jeffrey Shon
0.2069 %
350,000 0.2069 % 7 350 $
J. Lievonen
0.000000 %
0 0.000000 % - $

Company contact information

Quest PharmaTech, Inc.

8123 Roper Road NW

T6E 6S4, Edmonton

+

http://www.questpharmatech.com
address Quest PharmaTech Inc.(QPT)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
QUEST PHARMATECH INC. Stock Quest PharmaTech Inc.
-63.64% 2.47M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+48.09% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. QPT Stock
  4. Company Quest PharmaTech Inc.